The Experience of Initiating Oral Adjuvant Treatment for Estrogen Receptor–Positive Breast Cancer
Jane Flanagan, PhD, RN, ANP-BC; Devin Tetler, MS, RN, AGPCNP-BC; Loren Winters, MSN, ANP-BC, OCN®; Kathryn Post, MS, APRN-BC; and Karleen Habin, MSN, RN, BC-CS
ONF
10.1188/16.ONF.e143-e152
Description
Purpose/Objectives: To describe the experience of women with estrogen receptor–positive breast cancer who are initiating oral adjuvant therapy and to determine what they describe as facilitating and/or hindering this experience.
Research Approach: Qualitative inquiry.
Setting: Massachusetts General Hospital Cancer Center in Boston.
Participants: 14 women aged 48–81 years.